Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   


OLIENA
Language recovery after stroke
App | Video | PDF (278 pp) | Web

  Prostate Cancer

  Free Subscription


Articles published in Int J Oncol

Retrieve available abstracts of 23 articles:
HTML format
Text format



Single Articles


    November 2018
  1. NUNEZ-IGLESIAS MJ, Novio S, Garcia-Santiago C, Cartea ME, et al
    Effects of 3-butenyl isothiocyanate on phenotypically different prostate cancer cells.
    Int J Oncol. 2018;53:2213-2223.
    PubMed     Text format     Abstract available


  2. APOSTOLATOS AH, Ratnayake WS, Win-Piazza H, Apostolatos CA, et al
    Inhibition of atypical protein kinase Ciota effectively reduces the malignancy of prostate cancer cells by downregulating the NF-kappaB signaling cascade.
    Int J Oncol. 2018;53:1836-1846.
    PubMed     Text format     Abstract available


    September 2018
  3. WU K, Na K, Chen D, Wang Y, et al
    Effects of non-steroidal anti-inflammatory drug-activated gene-1 on Ganoderma lucidum polysaccharides-induced apoptosis of human prostate cancer PC-3 cells.
    Int J Oncol. 2018 Sep 28. doi: 10.3892/ijo.2018.4578.
    PubMed     Text format     Abstract available


  4. TAN Y, Wang L, Du Y, Liu X, et al
    Inhibition of BRD4 suppresses tumor growth in prostate cancer via the enhancement of FOXO1 expression.
    Int J Oncol. 2018 Sep 27. doi: 10.3892/ijo.2018.4577.
    PubMed     Text format     Abstract available


    August 2018
  5. HAN G, Zhang X, Liu P, Yu Q, et al
    Knockdown of anti-silencing function 1B histone chaperone induces cell apoptosis via repressing PI3K/Akt pathway in prostate cancer.
    Int J Oncol. 2018 Aug 16. doi: 10.3892/ijo.2018.4526.
    PubMed     Text format     Abstract available


    July 2018
  6. LIU P, Liang Y, Jiang L, Wang H, et al
    CX3CL1/fractalkine enhances prostate cancer spinal metastasis by activating the Src/FAK pathway.
    Int J Oncol. 2018 Jul 18. doi: 10.3892/ijo.2018.4487.
    PubMed     Text format     Abstract available


    June 2018
  7. LIU X, Sun Z, Li D, Deng J, et al
    Polyphyllin I inhibits invasion and epithelial-mesenchymal transition via CIP2A/PP2A/ERK signaling in prostate cancer.
    Int J Oncol. 2018 Jun 29. doi: 10.3892/ijo.2018.4464.
    PubMed     Text format     Abstract available


    May 2018
  8. ZHANG J, Shao S, Han D, Xu Y, et al
    High mobility group box 1 promotes the epithelial-to-mesenchymal transition in prostate cancer PC3 cells via the RAGE/NF-kappaB signaling pathway.
    Int J Oncol. 2018 May 23. doi: 10.3892/ijo.2018.4420.
    PubMed     Text format     Abstract available


  9. OAK C, Khalifa AO, Isali I, Bhaskaran N, et al
    Diosmetin suppresses human prostate cancer cell proliferation through the induction of apoptosis and cell cycle arrest.
    Int J Oncol. 2018 May 16. doi: 10.3892/ijo.2018.4407.
    PubMed     Text format     Abstract available


    April 2018
  10. QI Y, Zhao W, Li M, Shao M, et al
    High C-X-C motif chemokine 5 expression is associated with malignant phenotypes of prostate cancer cells via autocrine and paracrine pathways.
    Int J Oncol. 2018 Apr 30. doi: 10.3892/ijo.2018.4388.
    PubMed     Text format     Abstract available


  11. CHENG L, Zang J, Dai HJ, Li F, et al
    Ubiquitin ligase CHIP functions as an oncogene and activates the AKT signaling pathway in prostate cancer.
    Int J Oncol. 2018 Apr 24. doi: 10.3892/ijo.2018.4377.
    PubMed     Text format     Abstract available


  12. LUO Y, Li M, Zuo X, Basourakos SP, et al
    betacatenin nuclear translocation induced by HIF1alpha overexpression leads to the radioresistance of prostate cancer.
    Int J Oncol. 2018 Apr 12. doi: 10.3892/ijo.2018.4368.
    PubMed     Text format     Abstract available


  13. DU Z, Li L, Sun W, Wang X, et al
    HepaCAM inhibits the malignant behavior of castration-resistant prostate cancer cells by downregulating Notch signaling and PF-3084014 (a gamma-secretase inhibitor) partly reverses the resistance of refractory prostate cancer to docetaxel and enzaluta
    Int J Oncol. 2018 Apr 12. doi: 10.3892/ijo.2018.4370.
    PubMed     Text format     Abstract available


    November 2017
  14. CHEN S, Nimick M, Cridge AG, Hawkins BC, et al
    Anticancer potential of novel curcumin analogs towards castrate-resistant prostate cancer.
    Int J Oncol. 2017 Nov 20. doi: 10.3892/ijo.2017.4207.
    PubMed     Text format     Abstract available


  15. EDWARDS DR, Moroz K, Zhang H, Mulholland D, et al
    PRL3 increases the aggressive phenotype of prostate cancer cells in vitro and its expression correlates with high-grade prostate tumors in patients.
    Int J Oncol. 2017 Nov 20. doi: 10.3892/ijo.2017.4208.
    PubMed     Text format     Abstract available


  16. XU W, Foster BA, Richards M, Bondioli KR, et al
    Characterization of prostate cancer cell progression in zebrafish xenograft model.
    Int J Oncol. 2017 Nov 6. doi: 10.3892/ijo.2017.4189.
    PubMed     Text format     Abstract available


    August 2017
  17. LU L, Li K, Mao YH, Qu H, et al
    Gold-chrysophanol nanoparticles suppress human prostate cancer progression through inactivating AKT expression and inducing apoptosis and ROS generation in vitro and in vivo.
    Int J Oncol. 2017 Aug 10. doi: 10.3892/ijo.2017.4095.
    PubMed     Text format     Abstract available


    June 2017
  18. CHEN W, Liu Y, Chen H, Ning H, et al
    Loss of miR-449a-caused PrLZ overexpression promotes prostate cancer metastasis.
    Int J Oncol. 2017 Jun 12. doi: 10.3892/ijo.2017.4038.
    PubMed     Text format     Abstract available


    May 2017
  19. BILIR B, Sharma NV, Lee J, Hammarstrom B, et al
    Effects of genistein supplementation on genomewide DNA methylation and gene expression in patients with localized prostate cancer.
    Int J Oncol. 2017 May 24. doi: 10.3892/ijo.2017.4017.
    PubMed     Text format     Abstract available


  20. OKATO A, Arai T, Kojima S, Koshizuka K, et al
    Dual strands of pre-miR150 (miR1505p and miR1503p) act as antitumor miRNAs targeting SPOCK1 in naive and castration-resistant prostate cancer.
    Int J Oncol. 2017 May 17. doi: 10.3892/ijo.2017.4008.
    PubMed     Text format     Abstract available


    April 2017
  21. LU S, Dong Z
    Overexpression of secretory phospholipase A2-IIa supports cancer stem cell phenotype via HER/ERBB-elicited signaling in lung and prostate cancer cells.
    Int J Oncol. 2017 Apr 19. doi: 10.3892/ijo.2017.3964.
    PubMed     Text format     Abstract available


    March 2017
  22. QIAN B, Yao Y, Liu C, Zhang J, et al
    SU6668 modulates prostate cancer progression by downregulating MTDH/AKT signaling pathway.
    Int J Oncol. 2017 Mar 22. doi: 10.3892/ijo.2017.3926.
    PubMed     Text format     Abstract available


    December 2016
  23. HARTING T, Stubbendorff M, Willenbrock S, Wagner S, et al
    The effect of dichloroacetate in canine prostate adenocarcinomas and transitional cell carcinomas in vitro.
    Int J Oncol. 2016;49:2341-2350.
    PubMed     Text format     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Prostate Cancer is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: